Literature DB >> 9706815

Atrial fibrillation amongst the Indo-Asian general practice population. The West Birmingham Atrial Fibrillation Project.

G Y Lip1, L Bawden, R Hodson, E Rutland, J Snatchfold, D G Beevers.   

Abstract

Whilst there are recognised ethnic differences in cardiovascular disease, with a higher prevalence of hypertension and complications such as stroke amongst black/Afro-Caribbean populations, and ischaemic heart disease being more prevalent amongst Indo-Asians, the literature describing the clinical epidemiology of atrial fibrillation (AF) in non-caucasian groups is scarce. To survey the clinical features and management amongst Indo-Asian patients with known AF, we studied patients from six general practices in the west of Birmingham. The six general practices had a combined practice population of 25051, from which, the Indo-Asian population was 14670. A total of 12 Indo-Asian patients (six male, six female; mean age, 67 years; range, 42 to 95 years) with known AF were identified, suggesting a prevalence of AF in Indo-Asians aged >50 years of 0.6%. Six patients had chronic AF, two had recent onset (defined as onset <six months) and four had paroxysmal AF. Five patients had a history of ischaemic heart disease, three had hypertension, seven had heart failure, two had alcohol excess, four had mitral valve disease, and one patient with paroxysmal AF had sick sinus syndrome. None could be classified as having lone AF. Only four patients were anticoagulated, but, of the remaining eight, who were not taking warfarin, six were taking aspirin. None of the patients had contraindications to warfarin, but one of the patients who was taking aspirin had poor compliance to warfarin. In this survey of a general practice Indo-Asian population of approximately 14670, we found 12 patients with known AF. More information on the clinical epidemiology of AF in non-caucasian groups is still needed and urgently required, in view of the public health implications of this common cardiac arrhythmia.

Entities:  

Mesh:

Year:  1998        PMID: 9706815     DOI: 10.1016/s0167-5273(98)00125-9

Source DB:  PubMed          Journal:  Int J Cardiol        ISSN: 0167-5273            Impact factor:   4.164


  6 in total

Review 1.  Oral anticoagulants for Asian patients with atrial fibrillation.

Authors:  Ian Sabir; Kaivan Khavandi; Jack Brownrigg; A John Camm
Journal:  Nat Rev Cardiol       Date:  2014-03-11       Impact factor: 32.419

Review 2.  Global epidemiology of atrial fibrillation.

Authors:  Faisal Rahman; Gene F Kwan; Emelia J Benjamin
Journal:  Nat Rev Cardiol       Date:  2014-08-12       Impact factor: 32.419

Review 3.  The Indian consensus guidance on stroke prevention in atrial fibrillation: An emphasis on practical use of nonvitamin K oral anticoagulants.

Authors:  Jamshed Dalal; Abhay Bhave; Abraham Oomman; Amit Vora; Anil Saxena; Dhiman Kahali; Fali Poncha; D S Gambhir; Jaydip Ray Chaudhuri; Nakul Sinha; Saumitra Ray; S S Iyengar; Suvro Banerjee; Upendra Kaul
Journal:  Indian Heart J       Date:  2015-11-24

4.  Initiation and persistence with warfarin therapy in atrial fibrillation according to ethnicity.

Authors:  Carolina Malta Hansen; Jonas Bjerring Olesen; Morten Lock Hansen; Aziza Azimi; Christian Torp-Pedersen; Helena Dominguez
Journal:  Front Pharmacol       Date:  2012-06-28       Impact factor: 5.810

5.  Prevalence of heart failure and atrial fibrillation in minority ethnic subjects: the Ethnic-Echocardiographic Heart of England Screening Study (E-ECHOES).

Authors:  Paramjit S Gill; Melanie Calvert; Russell Davis; Michael K Davies; Nick Freemantle; Gregory Y H Lip
Journal:  PLoS One       Date:  2011-11-16       Impact factor: 3.240

6.  Prospective national study of the prevalence, incidence, management and outcome of a large contemporary cohort of patients with incident non-valvular atrial fibrillation.

Authors:  Moti Haim; Moshe Hoshen; Orna Reges; Yardena Rabi; Ran Balicer; Morton Leibowitz
Journal:  J Am Heart Assoc       Date:  2015-01-21       Impact factor: 5.501

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.